IL37 and Hyperglycemia: Although GDM is a relatively short-term form of pathophysiological hyperglycaemia in pregnant women, associated with an highly inflammatory status in the micro-environment (12), reduced IL-37 may not be able to provide anti-inflammatory protection in both local (placental) and systemic responses, and consequently high levels of inflammation are induced in GDM pregnant women.